Feedback / Questions
Erbitux (cetuximab) - Eli Lilly, EMD Serono
WU-NK-101 - Wugen
https://www.businesswire.com/news/home/20230121005001/en/Wugen-Presents-Data-on-WU-NK-101-in-Combination-with-Cetuximab-in-Preclinical-Models-of-Advanced-Colorectal-Cancer-CRC-at-ASCO-Gastrointestinal-Cancers-Symposium
Jan 21, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next